Respeecher company
%20.jpg)
They leverage recent breakthroughs in the field of machine learning called deep learning which allow artificial neural networks to produce high quality synthetic speech. Up until now, these techniques have mainly been used for text-to-speech conversion. Because text contains very little prosodic information, this results in a rather monotone output. By doing speech-to-speech, we circumvent this problem, copying the intonation of the input speech to the output.
Investors
Technology:
P4 Medicine
Headquarters:
Kyiv, Kyyiv, Ukraine
Funding Status:
Seed
Founded Date:
2018-02-01
Last Funding Type:
Angel
Investors Number:
4
Estimated Revenue:
Less than $1M
Employee Number:
11-50
Total Funding:
$675.5K
Industry:
Artificial Intelligence, Data and Analytics, Hardware, Information Technology, Science and Engineering, Software
Investor Type:
For Profit